Trials / Completed
CompletedNCT00561132
Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance
Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Unidad de Investigacion Medica en Epidemiologia Clinica · Academic / Other
- Sex
- All
- Age
- 40 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vanadyl sulfate | 50 mg twice daily orally for a period of 4 weeks |
| OTHER | Magnesium oxide | Validation of similar appearance and weight to the intervention component orally 1 unit (\<50 mg) twice daily for a period of 4 weeks |
Timeline
- Start date
- 2003-11-01
- Completion
- 2004-11-01
- First posted
- 2007-11-20
- Last updated
- 2007-11-20
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00561132. Inclusion in this directory is not an endorsement.